S. Russell, K. Peng, J. Bell, and . Oncolytic-virotherapy, Oncolytic virotherapy, Nature Biotechnology, vol.311, issue.7, pp.658-670, 2012.
DOI : 10.1038/nbt.2287

J. Guillerme, M. Gregoire, F. Tangy, and J. Fonteneau, Antitumor Virotherapy by Attenuated Measles Virus (MV), Biology, vol.2, issue.2, pp.587-602, 2013.
DOI : 10.3390/biology2020587

P. Msaouel, I. Iankov, A. Dispenzieri, and E. Galanis, Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics, Current Pharmaceutical Biotechnology, vol.13, issue.9, pp.1732-1741, 2012.
DOI : 10.2174/138920112800958896

L. Heinzerling, V. Kunzi, P. Oberholzer, T. Kundig, H. Naim et al., Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells, Blood, vol.106, issue.7, pp.2287-2294, 2005.
DOI : 10.1182/blood-2004-11-4558

E. Galanis, L. Hartmann, W. Cliby, H. Long, P. Peethambaram et al., Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer, Cancer Research, vol.70, issue.3, pp.875-882, 2010.
DOI : 10.1158/0008-5472.CAN-09-2762

E. Galanis, P. Atherton, M. Maurer, K. Knutson, S. Dowdy et al., Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer, Cancer Research, vol.75, issue.1, pp.22-30, 2015.
DOI : 10.1158/0008-5472.CAN-14-2533

B. Anderson, T. Nakamura, S. Russell, and K. Peng, High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus, Cancer Research, vol.64, issue.14, pp.4919-4926, 2004.
DOI : 10.1158/0008-5472.CAN-04-0884

R. Dorig, A. Marcil, A. Chopra, and C. Richardson, The human CD46 molecule is a receptor for measles virus (Edmonston strain), Cell, vol.75, issue.2, pp.295-305, 1993.
DOI : 10.1016/0092-8674(93)80071-L

D. Naniche, G. Varior-krishnan, F. Cervoni, T. Wild, B. Rossi et al., Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus, J Virol, vol.67, pp.6025-6032, 1993.

M. Liszewski and J. Atkinson, Membrane cofactor protein, Curr Top Microbiol Immunol, vol.178, pp.45-60, 1992.

Z. Fishelson, N. Donin, S. Zell, S. Schultz, and M. Kirschfink, Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors, Molecular Immunology, vol.40, issue.2-4, pp.109-123, 2003.
DOI : 10.1016/S0161-5890(03)00112-3

N. Ravindranath and C. Shuler, Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas, Journal of Oral Pathology and Medicine, vol.90, issue.9, pp.560-567, 2006.
DOI : 10.1002/hed.10145

K. Peng, C. Teneyck, E. Galanis, K. Kalli, L. Hartmann et al., Intraperitoneal therapy of ovarian cancer using an engineered measles virus, Cancer Res, vol.62, pp.4656-4662, 2002.

M. Muhlebach, M. Mateo, P. Sinn, S. Prufer, K. Uhlig et al., Adherens junction protein nectin-4 is the epithelial receptor for measles virus, Nature, vol.199, pp.530-533, 2011.
DOI : 10.1038/nature10639
URL : https://hal.archives-ouvertes.fr/pasteur-00723299

R. Noyce, D. Bondre, M. Ha, L. Lin, G. Sisson et al., Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus, PLoS Pathogens, vol.105, issue.Pt 6, p.1002240, 2011.
DOI : 10.1371/journal.ppat.1002240.s002

M. Patel, B. Jacobson, H. Belgum, A. Raza, A. Sadiq et al., Measles Vaccine Strains for Virotherapy of Non???Small-Cell Lung Carcinoma, Journal of Thoracic Oncology, vol.9, issue.8, pp.1101-1110, 2014.
DOI : 10.1097/JTO.0000000000000214

M. Noll, S. Berchtold, J. Lampe, N. Malek, M. Bitzer et al., Primary resistance phenomena to oncolytic measles vaccine viruses, Int J Oncol, vol.43, pp.103-112, 2013.

S. Berchtold, J. Lampe, T. Weiland, I. Smirnow, S. Schleicher et al., Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis, Journal of Virology, vol.87, issue.6, pp.3484-3501, 2013.
DOI : 10.1128/JVI.02106-12

W. Schneider, M. Chevillotte, and C. Rice, Interferon-Stimulated Genes: A Complex Web of Host Defenses, Annual Review of Immunology, vol.32, issue.1, pp.513-545, 2014.
DOI : 10.1146/annurev-immunol-032713-120231

P. Mitchell, M. Emerman, and H. Malik, An evolutionary perspective on the broad antiviral specificity of MxA, Current Opinion in Microbiology, vol.16, issue.4, pp.493-499, 2013.
DOI : 10.1016/j.mib.2013.04.005

A. Gauvrit, S. Brandler, C. Sapede-peroz, N. Boisgerault, F. Tangy et al., Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response, Cancer Research, vol.68, issue.12, pp.4882-4892, 2008.
DOI : 10.1158/0008-5472.CAN-07-6265
URL : https://hal.archives-ouvertes.fr/pasteur-00330770

J. Guillerme, N. Boisgerault, D. Roulois, J. Menager, C. Combredet et al., Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells, Clinical Cancer Research, vol.19, issue.5, pp.1147-1158, 2013.
DOI : 10.1158/1078-0432.CCR-12-2733

F. Gueugnon, S. Leclercq, C. Blanquart, C. Sagan, L. Cellerin et al., Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma, The American Journal of Pathology, vol.178, issue.3, pp.1033-1042, 2011.
DOI : 10.1016/j.ajpath.2010.12.014

C. Erlenhofer, W. Duprex, B. Rima, V. Ter-meulen, and J. Schneider-schaulies, Analysis of receptor (CD46, CD150) usage by measles virus, Journal of General Virology, vol.83, issue.6, pp.1431-1436, 2002.
DOI : 10.1099/0022-1317-83-6-1431

S. Runge, K. Sparrer, C. Lassig, K. Hembach, A. Baum et al., In Vivo Ligands of MDA5 and RIG-I in Measles Virus-Infected Cells, PLoS Pathogens, vol.86, issue.4, p.1004081, 2014.
DOI : 10.1371/journal.ppat.1004081.s013

M. Diamond, M. Kinder, H. Matsushita, M. Mashayekhi, G. Dunn et al., Type I interferon is selectively required by dendritic cells for immune rejection of tumors, The Journal of Experimental Medicine, vol.134, issue.10, pp.1989-2003, 2011.
DOI : 10.4049/jimmunol.0803214

M. Fuertes, A. Kacha, J. Kline, S. Woo, D. Kranz et al., dendritic cells, The Journal of Experimental Medicine, vol.61, issue.10, pp.2005-2016, 2011.
DOI : 10.1158/0008-5472.CAN-07-5324

R. Lenci, M. Bevier, A. Brandt, J. Bermejo, A. Sucker et al., Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy, PLoS ONE, vol.33, issue.11, p.50692, 2012.
DOI : 10.1371/journal.pone.0050692.s012

J. Pavlovic, H. Arzet, H. Hefti, M. Frese, D. Rost et al., Enhanced virus resistance of transgenic mice expressing the human MxA protein, J Virol, vol.69, pp.4506-4510, 1995.

S. Schneider-schaulies, J. Schneider-schaulies, A. Schuster, M. Bayer, J. Pavlovic et al., Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells, J Virol, vol.68, pp.6910-6917, 1994.

J. Schoggins, D. Macduff, N. Imanaka, M. Gainey, B. Shrestha et al., Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity, Nature, vol.3, issue.7485, pp.691-695, 2014.
DOI : 10.1038/nature12862

J. Schoggins, S. Wilson, M. Panis, M. Murphy, C. Jones et al., A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, vol.81, issue.7344, pp.481-485, 2011.
DOI : 10.1038/nature09907

N. Boisgerault, J. Guillerme, D. Pouliquen, M. Mesel-lemoine, C. Achard et al., Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas, BioMed Research International, vol.20, issue.6, p.387362, 2013.
DOI : 10.1158/0008-5472.CAN-04-0884

S. Russell, M. Federspiel, K. Peng, C. Tong, D. Dingli et al., Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy, Mayo Clinic Proceedings, vol.89, issue.7, pp.926-933, 2014.
DOI : 10.1016/j.mayocp.2014.04.003

T. Hackett, S. Warner, D. Stefanowicz, F. Shaheen, D. Pechkovsky et al., Induction of Epithelial???Mesenchymal Transition in Primary Airway Epithelial Cells from Patients with Asthma by Transforming Growth Factor-??1, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.2, pp.122-133, 2009.
DOI : 10.1164/rccm.200811-1730OC

C. Combredet, V. Labrousse, L. Mollet, C. Lorin, F. Delebecque et al., A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice, Journal of Virology, vol.77, issue.21, pp.11546-11554, 2003.
DOI : 10.1128/JVI.77.21.11546-11554.2003